{"database": "lobbying", "table": "lobbying_activities", "rows": [[2463365, "fa6dfd70-58b1-4fda-9ae3-31f9a7ea52ea", "Q2", "AMERICAN PHARMACISTS ASSOCIATION", 3071, "AMERICAN PHARMACISTS ASSOCIATION", 2020, "second_quarter", "CSP", "HR 5663 - \"Safeguarding Therapeutics Act\". To amend the Federal Food, Drug, and Cosmetic Act to give authority to the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to destroy counterfeit devices.", "HOUSE OF REPRESENTATIVES,SENATE", null, 34000, 0, 0, "2020-07-10T12:21:58.880000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2463365"], "units": {}, "query_ms": 7.64887995319441, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}